ArticleCirculation reports2026
Association of Admission Anemia Severity With Frailty and Hospitalization-Associated Disability at Discharge and 1-Year Mortality After Discharge in Patients With Heart Failure: A Multicenter Cohort Analysis of the J-Proof HF Registry.
Article in Circulation reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Anemia and functional decline are common in older patients hospitalized for heart failure. We examined whether anemia severity at admission was associated with frailty at discharge, hospitalization-associated disability (HAD), and 1-year mortality after discharge. Methods and Results: This multicenter analysis of the J-Proof HF registry included 8,691 patients aged ≥65 years, classified as non-anemia, anemia, or severe anemia (hemoglobin <10 g/dL). Frailty was defined using the Japanese Cardiovascular Health Study criteria (≥3), and HAD as a ≥5-point decline in the Barthel Index from pre-admission to discharge. Multivariable logistic regression and Cox models were used. Higher anemia severity was independently associated with frailty at discharge in both the primary and fully expanded models (fully expanded model: odds ratio 1.18; 95% confidence interval 1.10-1.27). The association with HAD was significant in the primary model but was attenuated after adjustment for serum albumin and was no longer statistically significant in the fully expanded model. Anemia and severe anemia were associated with higher 1-year mortality after adjustment for frailty and HAD, but these associations were also attenuated and no longer significant in the fully expanded model. Conclusions: Admission anemia severity was consistently associated with frailty at discharge, whereas associations with HAD and 1-year mortality were attenuated after expanded adjustment. Admission hemoglobin may serve as an early marker of functional vulnerability and broader clinical complexity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.